PULMONARY FUNCTION TEST DECREASED side effect
What is PULMONARY FUNCTION TEST DECREASED ?Drugs associated with PULMONARY FUNCTION TEST DECREASED
ADVAIR AERX ATIVAN CIPROFLOXACIN COREG ENDOTOXIN EXUBERA INSULIN MYFORTIC PROAIR RAPAMUNE SPIRIVA TACROLIMUS VELCADEPULMONARY FUNCTION TEST DECREASED : Aerx Side Effects Report #5654615-3
Physician from UNITED KINGDOM reported AERX SOLUTION problem on Feb 27, 2008. Female patient, weighting 124.8 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with AERX SOLUTION. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, . AERX SOLUTION dosage: unknown. During the same period patient was treated with INSULIN DETEMIR FLEXPEN, ASPIRIN, FLUVASTATIN, SERTRALINE, ESTRACOMBI. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Endotoxin Side Effects Report #5688318-6
ENDOTOXIN problem was reported by a Physician from UNITED STATES on Mar 28, 2008. Male patient, weighting 194.4 lb, was treated with ENDOTOXIN. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, . ENDOTOXIN dosage: unknown. During the same period patient was treated with AMOXICILLIN, LACTOSE. Patient was hospitalized. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Aerx Side Effects Report #5514226-7
Physician from UNITED KINGDOM reported AERX SOLUTION problem on Nov 02, 2007. Female patient, weighting 124.8 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with AERX SOLUTION. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, . AERX SOLUTION dosage: unknown. During the same period patient was treated with INSULIN DETEMIR FLEXPEN, ASPIRINE, FLUVASTATIN, SERTRALINE, ESTRACOMBI. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Insulin Side Effects Report #5518029-9
INSULIN DETEMIR FLEXPEN problem was reported by a Physician from UNITED KINGDOM on Nov 02, 2007. Female patient, weighting 124.8 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with INSULIN DETEMIR FLEXPEN. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, . INSULIN DETEMIR FLEXPEN dosage: unknown. During the same period patient was treated with AERX SOLUTION, ASPIRINE, FLUVASTATIN, SERTRALINE, ESTRACOMBI. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Spiriva Side Effects Report #5524013-1
Physician from UNITED STATES reported SPIRIVA problem on Oct 31, 2007. Female patient was diagnosed with asthma, chronic obstructive pulmonary disease and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, tachycardia, thyroid function test abnormal, thyroxine increased, . SPIRIVA dosage: unknown. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Ciprofloxacin Side Effects Report #5389364-2
CIPROFLOXACIN problem was reported by a Pharmacist from JAPAN on July 12, 2007. Female patient was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, . CIPROFLOXACIN dosage: UNIT DOSE: 200 MG. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Velcade Side Effects Report #5392963-5
Physician from UNITED STATES reported VELCADE problem on July 06, 2007. Male patient, 73 years of age, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, pulmonary toxicity, . VELCADE dosage: 2.75 MG, INTRAVENOUS. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN PFS, DEXAMETHASONE, CLONIDINE, CRESTOR, ASPIRIN. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Ciprofloxacin Side Effects Report #5389364-2
CIPROFLOXACIN problem was reported by a Pharmacist from JAPAN on July 12, 2007. Female patient was treated with CIPROFLOXACIN. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, . CIPROFLOXACIN dosage: UNIT DOSE: 200 MG. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Velcade Side Effects Report #5392963-5
Physician from UNITED STATES reported VELCADE problem on July 06, 2007. Male patient, 73 years of age, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, pulmonary toxicity, . VELCADE dosage: 2.75 MG, INTRAVENOUS. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN PFS, DEXAMETHASONE, CLONIDINE, CRESTOR, ASPIRIN. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Myfortic Side Effects Report #5672380-0
MYFORTIC VS EVEROLIMUS problem was reported by a Physician from SWITZERLAND on Mar 11, 2008. Female patient, 35 years of age, weighting 112.4 lb, was diagnosed with lung transplant and was treated with MYFORTIC VS EVEROLIMUS. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, pulmonary function test decreased, respiratory tract infection, . MYFORTIC VS EVEROLIMUS dosage: 360 MG 2 X 4. During the same period patient was treated with MYFORTIC VS EVEROLIMUS. Patient was hospitalized. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Proair Side Effects Report #5586308-5
Consumer or non-health professional from UNITED STATES reported PROAIR HFA problem on Jan 07, 2008. Male patient, weighting 235.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with PROAIR HFA. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, respiratory disorder, . PROAIR HFA dosage: unknown. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Tacrolimus Side Effects Report #5578689-3
TACROLIMUS problem was reported by a Physician from GERMANY on Dec 11, 2007. Female patient, 60 years of age, was diagnosed with lung transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: lung transplant rejection, pulmonary function test decreased, . TACROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Advair Side Effects Report #5498304-7
Consumer or non-health professional from UNITED STATES reported ADVAIR DISKUS problem on June 04, 2007. Male patient, 66 years of age, was diagnosed with asthma and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: pulmonary function test decreased, respiratory disorder, . ADVAIR DISKUS dosage: unknown. During the same period patient was treated with COMBIVENT, LIPITOR, METOPROLOL TARTRATE, WARFARIN, ASPIRIN. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Ativan Side Effects Report #5657988-0
ATIVAN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 29, 2008. Female patient, weighting 77.00 lb, was diagnosed with anxiety and was treated with ATIVAN. After drug was administered, patient experienced the following problems/side effects: coma, pneumonia, pulmonary function test decreased, respiratory disorder, total lung capacity decreased, . ATIVAN dosage: (0.25 MG BID ORAL). During the same period patient was treated with DORIBAX. Patient died on 02/09/2008.
PULMONARY FUNCTION TEST DECREASED : Coreg Side Effects Report #5515495-X
Consumer or non-health professional from UNITED STATES reported COREG problem on Mar 06, 2007. Male patient, 88 years of age, was diagnosed with atrial fibrillation and was treated with COREG. After drug was administered, patient experienced the following problems/side effects: dyspnoea exertional, pruritus, pulmonary function test decreased, . COREG dosage: 6.25MG TWICE PER DAY. During the same period patient was treated with COUMADIN, PREVACID. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Exubera Side Effects Report #5549626-2
EXUBERA problem was reported by a Physician from UNITED STATES on Aug 23, 2007. Female patient, 60 years of age, was treated with EXUBERA. After drug was administered, patient experienced the following problems/side effects: chest pain, cough, pulmonary function test decreased, . EXUBERA dosage: unknown. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Advair Side Effects Report #5497304-0
Consumer or non-health professional from UNITED STATES reported ADVAIR DISKUS problem on Nov 06, 2006. Female patient, 57 years of age, was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder, pulmonary function test decreased, . ADVAIR DISKUS dosage: unknown. During the same period patient was treated with ALBUTEROL, SINGULAIR. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Advair Side Effects Report #5497592-0
ADVAIR DISKUS problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2007. Female patient, 58 years of age, was diagnosed with asthma and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: pharyngolaryngeal pain, pulmonary function test decreased, . ADVAIR DISKUS dosage: unknown. During the same period patient was treated with SYNTHROID, KLONOPIN, LEXAPRO, XOPENEX. Patient recovered.
PULMONARY FUNCTION TEST DECREASED : Rapamune Side Effects Report #5443658-0
Health Professional from AUSTRALIA reported RAPAMUNE problem on Sept 03, 2007. Male patient, weighting 158.7 lb, was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, lung infiltration, pulmonary function test decreased, pyrexia, . RAPAMUNE dosage: 1 MG DAILY. During the same period patient was treated with CALTRATE, HYOSCINE, DILTIAZEM, DOXYCYCLINE HYDROCHLORIDE. Patient recovered.